Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
07 2021
Historique:
revised: 07 05 2021
received: 14 03 2021
accepted: 17 05 2021
entrez: 9 6 2021
pubmed: 10 6 2021
medline: 16 6 2021
Statut: ppublish

Résumé

Syrian golden hamsters (Mesocricetus auratus) infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) manifests lung pathology. In this study, efforts were made to check the infectivity of a local SARS-CoV-2 isolate in a self-limiting and non-lethal hamster model and evaluate the differential expression of lung proteins during acute infection and convalescence. The findings of this study confirm the infectivity of this isolate in vivo. Analysis of clinical parameters and tissue samples show the pathophysiological manifestation of SARS-CoV-2 infection similar to that reported earlier in COVID-19 patients and hamsters infected with other isolates. However, diffuse alveolar damage (DAD), a common histopathological feature of human COVID-19 was only occasionally noticed. The lung-associated pathological changes were very prominent on the 4th day post-infection (dpi), mostly resolved by 14 dpi. Here, we carried out the quantitative proteomic analysis of the lung tissues from SARS-CoV-2-infected hamsters on day 4 and day 14 post-infection. This resulted in the identification of 1585 proteins of which 68 proteins were significantly altered between both the infected groups. Pathway analysis revealed complement and coagulation cascade, platelet activation, ferroptosis, and focal adhesion as the top enriched pathways. In addition, we also identified altered expression of two pulmonary surfactant-associated proteins (Sftpd and Sftpb), known for their protective role in lung function. Together, these findings will aid in understanding the mechanism(s) involved in SARS-CoV-2 pathogenesis and progression of the disease.

Identifiants

pubmed: 34105201
doi: 10.1096/fj.202100431R
pmc: PMC8206718
doi:

Substances chimiques

Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e21713

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : DBT-BIRAC, India
ID : BT/CS0004/CS/02/20

Informations de copyright

© 2021 Federation of American Societies for Experimental Biology.

Références

Lancet. 2020 Aug 1;396(10247):320-332
pubmed: 32682491
Nature. 2020 Jul;583(7818):834-838
pubmed: 32408338
Mol Cancer Res. 2014 Sep;12(9):1195-204
pubmed: 24807918
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595
pubmed: 32571934
F1000Res. 2020 Aug 7;9:943
pubmed: 33299552
Lancet Respir Med. 2020 Jul;8(7):681-686
pubmed: 32473124
Heliyon. 2020 Dec 07;6(12):e05672
pubmed: 33313438
Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1217-29
pubmed: 9351625
J Immunol. 2003 Jul 15;171(2):1051-60
pubmed: 12847279
J Immunol. 2019 Sep 1;203(5):1288-1297
pubmed: 31324725
PLoS Pathog. 2013 Mar;9(3):e1003285
pubmed: 23555273
Blood. 2011 Nov 3;118(18):4789-97
pubmed: 21908427
Int J Mol Sci. 2019 Apr 08;20(7):
pubmed: 30965568
Cell. 2020 Nov 12;183(4):1070-1085.e12
pubmed: 33031744
Urine (Amst). 2020;2:1-8
pubmed: 33688631
Front Microbiol. 2020 Aug 26;11:1905
pubmed: 32982999
Semin Immunopathol. 2012 Jan;34(1):43-62
pubmed: 22037947
Clin Infect Dis. 2021 Aug 2;73(3):e719-e734
pubmed: 33515458
Physiol Rev. 2016 Oct;96(4):1211-59
pubmed: 27489307
Nature. 2020 Oct;586(7830):509-515
pubmed: 32967005
Arch Immunol Ther Exp (Warsz). 2013 Aug;61(4):309-19
pubmed: 23563866
Platelets. 2015;26(2):138-42
pubmed: 24679181
FASEB J. 2021 Jul;35(7):e21713
pubmed: 34105201
Front Immunol. 2020 Oct 01;11:584310
pubmed: 33117399
iScience. 2021 Feb 19;24(2):102054
pubmed: 33521604
Mol Cell Proteomics. 2020 Nov;19(11):1749-1759
pubmed: 32788344
Cell. 2021 Feb 4;184(3):775-791.e14
pubmed: 33503446
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Am J Respir Crit Care Med. 1999 Dec;160(6):1843-50
pubmed: 10588595
Endocr Rev. 2007 Dec;28(7):707-25
pubmed: 17916741
Microbes Infect. 2012 Jan;14(1):17-25
pubmed: 21945366
Emerg Microbes Infect. 2020 Dec;9(1):2673-2684
pubmed: 33251966
FEBS J. 2021 Sep;288(17):5190-5200
pubmed: 33098359
Clin Infect Dis. 2020 Dec 3;71(9):2428-2446
pubmed: 32215622
Lancet Respir Med. 2020 Dec;8(12):1201-1208
pubmed: 32861276
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154
pubmed: 32602883
Lancet Infect Dis. 2014 Jan;14(1):57-69
pubmed: 24239327
Int J Infect Dis. 2020 Aug;97:303-305
pubmed: 32497811
Nature. 2017 Apr 6;544(7648):105-109
pubmed: 28329764
Am J Reprod Immunol. 2020 Feb;83(2):e13208
pubmed: 31702086
Expert Opin Biol Ther. 2012 Jan;12(1):37-51
pubmed: 22074294
Rev Panam Salud Publica. 2020 Jun 01;44:e72
pubmed: 32547616
Lancet Rheumatol. 2020 Jul;2(7):e437-e445
pubmed: 32835247
Life Sci. 2020 Nov 1;260:118431
pubmed: 32946915
Int J Chron Obstruct Pulmon Dis. 2016 Sep 20;11:2321-2327
pubmed: 27703342
J R Soc Interface. 2013 Dec 18;11(92):20130950
pubmed: 24352673
Expert Rev Proteomics. 2006 Feb;3(1):1-3
pubmed: 16445344
Semin Nephrol. 2013 Nov;33(6):479-92
pubmed: 24161035
Intensive Care Med. 2020 Jun;46(6):1089-1098
pubmed: 32367170
Signal Transduct Target Ther. 2020 Oct 15;5(1):240
pubmed: 33060566
Physiol Rev. 2020 Jul 1;100(3):1065-1075
pubmed: 32216698
Nat Med. 2020 Nov;26(11):1694-1700
pubmed: 32884153
Lung. 2020 Oct;198(5):777-784
pubmed: 32918573
Mol Aspects Med. 2014 Dec;40:1-116
pubmed: 25010388
Nat Rev Mol Cell Biol. 2004 Dec;5(12):998-1012
pubmed: 15573137
Sci Rep. 2020 Nov 10;10(1):19395
pubmed: 33173052
Clin Infect Dis. 2020 Nov 19;71(16):2139-2149
pubmed: 32472679
Cell Syst. 2020 Jul 22;11(1):11-24.e4
pubmed: 32619549
J Med Virol. 2020 Oct;92(10):1741-1742
pubmed: 32246503
Subcell Biochem. 2017;82:405-456
pubmed: 28101869
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Blood. 2011 Sep 15;118(11):3172-81
pubmed: 21768297
Curr Opin Virol. 2021 Jun;48:73-81
pubmed: 33906125
Sci Rep. 2020 Dec 29;10(1):22418
pubmed: 33376242
Nucleic Acids Res. 2021 Jan 8;49(D1):D394-D403
pubmed: 33290554
Proc Natl Acad Sci U S A. 2020 Nov 10;117(45):28336-28343
pubmed: 33082228
Cell Death Dis. 2020 Feb 3;11(2):88
pubmed: 32015325
Nature. 2014 May 29;509(7502):575-81
pubmed: 24870542
Anal Chem. 2003 Apr 15;75(8):1895-904
pubmed: 12713048
Sci Rep. 2019 Oct 29;9(1):15507
pubmed: 31664114
Cell. 2020 Jul 9;182(1):59-72.e15
pubmed: 32492406
Expert Opin Biol Ther. 2015;15 Suppl 1:S139-45
pubmed: 26096726
Front Pharmacol. 2021 Jan 14;11:579330
pubmed: 33568991
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Cell Rep Med. 2020 Oct 20;1(7):100121
pubmed: 32984855
Crit Care. 2020 Oct 6;24(1):594
pubmed: 33023604

Auteurs

Voddu Suresh (V)

Institute of Life Sciences, Bhubaneswar, India.
Regional Centre for Biotechnology, Faridabad, India.

Varshasnata Mohanty (V)

Institute of Life Sciences, Bhubaneswar, India.

Kiran Avula (K)

Institute of Life Sciences, Bhubaneswar, India.
Regional Centre for Biotechnology, Faridabad, India.

Arup Ghosh (A)

Institute of Life Sciences, Bhubaneswar, India.
Kalinga Institute of Industrial Technology, Bhubaneswar, India.

Bharati Singh (B)

Institute of Life Sciences, Bhubaneswar, India.
Kalinga Institute of Industrial Technology, Bhubaneswar, India.

Rajendra Kumar Reddy (RK)

Institute of Life Sciences, Bhubaneswar, India.

Deepti Parida (D)

Institute of Life Sciences, Bhubaneswar, India.
Regional Centre for Biotechnology, Faridabad, India.

Amol Ratnakar Suryawanshi (AR)

Institute of Life Sciences, Bhubaneswar, India.

Sunil Kumar Raghav (SK)

Institute of Life Sciences, Bhubaneswar, India.

Soma Chattopadhyay (S)

Institute of Life Sciences, Bhubaneswar, India.

Punit Prasad (P)

Institute of Life Sciences, Bhubaneswar, India.

Rajeeb Kumar Swain (RK)

Institute of Life Sciences, Bhubaneswar, India.

Rupesh Dash (R)

Institute of Life Sciences, Bhubaneswar, India.

Ajay Parida (A)

Institute of Life Sciences, Bhubaneswar, India.

Gulam Hussain Syed (GH)

Institute of Life Sciences, Bhubaneswar, India.

Shantibhusan Senapati (S)

Institute of Life Sciences, Bhubaneswar, India.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH